Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Aparicio

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 3, 2023
SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022)Ana Fernández Montes, Vicente Alonso, Enrique Aranda, et al.
Clinical Colorectal Cancer|December 17, 2005
FOLFOX alternated with FOLFIRI as first-line chemotherapy for metastatic colorectal cancerJorge Aparicio, Carlos Fernandez-Martos, Jose M Vincent, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 14, 2005
Carboplatin and tegafur-uracil concomitant with standard radiotherapy in the management of locally advanced head and neck cancerAngel Segura Huerta, Roberto Díaz-Beveridge, José A Pérez-Fidalgo, et al.
Tumori|June 6, 2015
Adjuvant chemoradiation in gastric cancer: long-term outcomes and prognostic factors from a single institutionGema Bruixola, Ángel Segura, Robert Díaz-Beveridge, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 5, 2010
Long-term results of neoadjuvant chemotherapy and combined chemoradiotherapy before surgery in the management of locally advanced oesophageal cancer: a single-centre experienceRobert Díaz, Gaspar Reynes, Alejandro Tormo, et al.
Journal of Pediatric Hematology/Oncology|May 2, 2015
Multimodality Treatment of Pediatric and Adult Patients With Ewing Sarcoma: A Single-institution ExperienceRobert Diaz-Beveridge, David Lorente, Barbara Torres, et al.
Molecular Cancer|January 20, 2023
A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancerKeisuke Okuno, Raju Kandimalla, Marta Mendiola, et al.
Oncology|April 6, 2005
First-line treatment with irinotecan and raltitrexed in metastatic colorectal cancer. Mature results of a multicenter phase II studyJorge Aparicio, José M Vicent, Inmaculada Maestu, et al.
Plos One|January 14, 2014
A phase I, dose-finding study of sorafenib in combination with gemcitabine and radiation therapy in patients with unresectable pancreatic adenocarcinoma: a Grupo Español Multidisciplinario en Cáncer Digestivo (GEMCAD) studyJorge Aparicio, Carmen García-Mora, Marta Martín, et al.
Cancer Chemotherapy and Pharmacology|July 10, 2003
A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancerJuan José Reina, Jorge Aparicio, Javier Salvador, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 3, 2023
SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022)Ana Fernández Montes, Vicente Alonso, Enrique Aranda, et al.
Clinical Colorectal Cancer|December 17, 2005
FOLFOX alternated with FOLFIRI as first-line chemotherapy for metastatic colorectal cancerJorge Aparicio, Carlos Fernandez-Martos, Jose M Vincent, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 14, 2005
Carboplatin and tegafur-uracil concomitant with standard radiotherapy in the management of locally advanced head and neck cancerAngel Segura Huerta, Roberto Díaz-Beveridge, José A Pérez-Fidalgo, et al.
Tumori|June 6, 2015
Adjuvant chemoradiation in gastric cancer: long-term outcomes and prognostic factors from a single institutionGema Bruixola, Ángel Segura, Robert Díaz-Beveridge, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 5, 2010
Long-term results of neoadjuvant chemotherapy and combined chemoradiotherapy before surgery in the management of locally advanced oesophageal cancer: a single-centre experienceRobert Díaz, Gaspar Reynes, Alejandro Tormo, et al.
Journal of Pediatric Hematology/Oncology|May 2, 2015
Multimodality Treatment of Pediatric and Adult Patients With Ewing Sarcoma: A Single-institution ExperienceRobert Diaz-Beveridge, David Lorente, Barbara Torres, et al.
Molecular Cancer|January 20, 2023
A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancerKeisuke Okuno, Raju Kandimalla, Marta Mendiola, et al.
Oncology|April 6, 2005
First-line treatment with irinotecan and raltitrexed in metastatic colorectal cancer. Mature results of a multicenter phase II studyJorge Aparicio, José M Vicent, Inmaculada Maestu, et al.
Plos One|January 14, 2014
A phase I, dose-finding study of sorafenib in combination with gemcitabine and radiation therapy in patients with unresectable pancreatic adenocarcinoma: a Grupo Español Multidisciplinario en Cáncer Digestivo (GEMCAD) studyJorge Aparicio, Carmen García-Mora, Marta Martín, et al.
Cancer Chemotherapy and Pharmacology|July 10, 2003
A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancerJuan José Reina, Jorge Aparicio, Javier Salvador, et al.
Pageof 10